A Novel Drosophila-based Drug Repurposing Platform Identified Fingolimod As a Potential Therapeutic for TDP-43 ProteinopathyLuca Lo Piccolo, Salinee Jantrapirom|Neurotherapeutics|2023Cited by 9
Dystrophin is required for normal synaptic gain in the Drosophila olfactory circuitSalinee Jantrapirom, Saranyapin Potikanond, Jing W. Wang et al.|Brain Research|2019Cited by 1